[VIRTUAL] Longitudinal profiling of mucosal immune cell composition using multiplex immunohistochemistry identifies drug- and response-specific patterns in Ulcerative Colitis

Remicade (infliximab) - Merck (MSD), Mitsubishi Tanabe, J&J

Entyvio (vedolizumab) - Takeda

olamkicept (FE999301) - Ferring

Volk, V.1; Aden, K.2; Tran, F.2; Mishra, N.3; Bernardes, J.3; Röcken, C.4; Schreiber, S.2; Feuerhake, F.1; Rosenstiel, P.3

May 5, 2021